[Marketwired] - Prima BioMed Ltd is pleased to announce that it has activated a substantial number of additional clinical trial sites in Belgium, Bulgaria, Germany, Lithuania, and Latvia. CANVAS is a phase 2/3 study of ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment